OECD highlights the progress made in laboratory systems in the EU/EEA since the implementation of EULabCap
The OECD report ‘Health at a Glance: Europe 2018’ presents comparative analyses of the health status of EU citizens and the performance of the health systems. In the chapter ‘Public health capacity to control infectious disease threats’ OECD summarises the EULabCap indicator results and highlights the national improvements made in 24 EU countries since 2013.
Strong health systems depend on the ability to detect emerging diseases accurately in time to stop outbreaks and prevent major international crises such as the recent Ebola epidemic. Hence, it is important that laboratory systems have the necessary capabilities and capacities for reliable communicable disease surveillance control.
The assessments done through the EULabCap system show that 24 EU countries have reached the target set at the EU level by taking actions to address gaps. Capabilities to diagnose EU notifiable diseases and antimicrobial resistance as well as laboratory contribution to surveillance networks are well in line with EU legislation and case definitions across the EU.
However, some gaps and inefficiencies still need to be addressed, including upgrading surveillance programmes to integrate microbial genomic sequencing methods.
EU Laboratory Capability Monitoring System (EULabCap): Report on 2016 survey of EU/EEA country capabilities and capacities
2 May 2018 - This report for 2016, which presents the indicator results for EU and EEA (European Economic Area) countries, aims to help policymakers identify possible areas for action and to evaluate the impact of capacity strengthening activities and health system reforms.
Surveillance of antimicrobial resistance in Europe 2017
15 Nov 2018 - EARS-Net data for 2017 show that antimicrobial resistance remains a serious threat in Europe.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2017
12 Nov 2018 - This report provides an analysis of the external quality assessment (EQA) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2017.
Rapid risk assessment: Chlamydia trachomatis false-negative test results by Aptima Combo 2 CT/NG assay (Hologic) in the EU/EEA, 2019
Collection and analysis of whole genome sequencing data from food-borne pathogens and other relevant microorganisms isolated from human, animal, food, feed and food/feed environmental samples in the joint ECDC–EFSA molecular typing database
Molecular and genomic typing
Molecular typing of pathogens that cause infectious diseases complements the traditional epidemiological surveillance by providing appropriate discriminatory analyses to foster the rapid and early detection of widespread international outbreaks.Read more
Laboratory capacity and capability
The primary goal of the EU Laboratory Capability Monitoring System is to assess the capacity and capability of microbiology laboratories at national and EU level.Read more
Microbiology laboratories provide a first line of defence against health threats from communicable diseases and antimicrobial resistance. The ECDC provides scientific advice, capacity building activities and operational support to foster capable and responsive public health microbiology services for the European Union and beyond.Read more